Topics

Pediatric-type diffuse low-grade gliomas | Treatment | Targeted therapy | Dabrafenib

Home > Publications > Topics > Pediatric-type diffuse low-grade gliomas > Treatment > Targeted therapy > Dabrafenib

Campino GA, Shrot S, Constantini S, Roth J, Toren A, Lurye M, Yalon-Oren M.
Significant clinical and radiologic response to targeted therapy in pediatric cervicomedullary low-grade gliomas harboring the BRAFV600E mutation.
Childs Nerv Syst. 2025 Dec 21;41(1):429. doi: 10.1007/s00381-025-07084-w. PMID: 41423525. Case report. ˍ